1. Naming prescription drugs in promotional copy
Botulinum toxin (sold as Botox, Dysport, Xeomin), hyaluronic-acid dermal fillers (Juvederm, Restylane), and bimatoprost (Latisse) are prescription drugs in Canada. Section 3 of the Food and Drugs Act read with Schedule A restricts how prescription products can be advertised to the general public. Health Canada's guidance on the distinction between advertising and other activities sets out when a website description crosses from information into advertising.
Practical translation for a Toronto med spa homepage: a "Book Botox in Yorkville from $8/unit" headline is the textbook example of what the rule prohibits. A treatment page that describes the procedure, the consultation, the provider, and the conditions under which it may be appropriate is permitted. The line is real and we draft against it.
